TABLE 3.
Mecamylamine-sensitive steady-state activation of α4β2* nAChR, relative to ACh maximum-evoked transient responses recorded in oocytes
| (α4)3(β2)2 | (α4)2(β2)3 | (α4)2(β2)2α5 | |
|---|---|---|---|
| % | |||
| Nicotine | 1.8 ± 0.1 (300 nM) | 7 ± 1 (300 nM) | 2.5 ± 1 (100 nM) |
| Cytisine | 1.1 ± 0.2 (300 nM) | 1.4 ± 0.1 (100 nM) | 2.5 ± 0.5 (1 μM) |
| Varenicline | 1.7 ± 0.2 (1 μM) | 2.1 ± 0.4 (30 nM) | 2.5 ± 0.5 (100 nM) |